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ABSTRACT: Microcystins (MCs) are a group of biotoxins
(>150) produced by cyanobacteria, with a worldwide
distribution. MCs are hepatotoxic, and acute exposure causes
severe liver damage in humans and animals. Rapid and cheap
methods of analysis are therefore required to protect people and
livestock, especially in developing countries. To include as many
MCs as possible in a single analysis, we developed a new
competitive ELISA. Ovine polyclonal antibodies were raised
using an immunogen made by conjugating a mixture of
microcystins to cationised bovine serum albumin, and the
plate-coating antigen was prepared by conjugating [Asp3]MC-
RY to ovalbumin. This strategy was used also to minimize speciﬁcity for particular microcystin congeners. Cross-reactivity studies
indicate that the ELISA has broad speciﬁcity to microcystins and also detects nodularin, providing a sensitive and rapid analytical
method for screening large numbers of samples. The limit of quantitation for microcystins in drinking water is 0.04 μg/L, well
below the WHO’s maximum recommendation of 1 μg/L. The ELISA can be used for quantifying total microcystins in various
matrices, including drinking water, cyanobacterial cultures, extracts, and algal blooms, and may be useful in detecting metabolites
and conjugates of MCs.
■ INTRODUCTION
Cyanobacterial toxins can occur in drinking water reservoirs
and recreational lakes worldwide, causing gastroenteritis, skin
reactions, and liver damage and represent an acute and chronic
risk for human and animal health. Lethal poisonings have been
recorded in sheep, cattle, horses, pigs, dogs, ﬁsh, rodents,
amphibians, waterfowl, bats, rhinoceros, wildebeest, and
zebras.1−3 In Kenya and Tanzania, mass mortalities of lesser
ﬂamingos and other animals have been attributed to
cyanotoxins.4−6 Acute cyanotoxin poisoning in humans is rare
because water containing high concentrations of cyanobacteria
has a foul smell and taste. Nevertheless, cyanotoxins are a
health risk in developing countries due to chronic exposure to
low levels of cyanotoxins in the drinking water. High nutrient
enrichments in many South African surface water resources
result in eutrophication-related problems and high concen-
trations of cyanotoxins such as microcystins.7−9 Only 21% of
households in rural South Africa have access to piped indoor
water,8 many water treatment plants in rural areas do not
produce water of acceptable quality,10 and the remaining rural
households depend on what is available in lakes, streams, and
wells. There is therefore a pressing need for rapid, reliable,
rugged, and aﬀordable screening tests for cyanotoxins in such
situations.
Microcystins (MC) (Figure 1) are toxic cyclic heptapeptides
produced by various cyanobacterial genera, including Micro-
cystis, Anabaena, Hapalosiphon, Oscillatoria, Planktothrix, and
Nostoc11 and are one of the most commonly reported classes of
cyanobacterial toxins. The most frequently reported and most
toxic microcystin is MC-LR12 (Figure 1), where L and R
represent the amino acids leucine and arginine at the variable 2-
and 4-positions, respectively.13,14 Other variants regularly
reported are MC-LA,15 -YR, and -RR,13−16 although >150
analogues have been reported.17,18 Nodularins (NOD) (Figure
S1, Supporting Information) are related pentapeptides,
produced by cyanobacteria of the genus Nodularia11 with ca.
10 analogues reported.17,18 The World Health Organization19
has proposed a provisional guideline value of 1 μg/L of MC-LR
(free and cell-bound toxin) in drinking water,20 stating that “It
is important to measure total microcystins, which includes
microcystins occurring free in water and microcystins bound to
or inside cyanobacterial cells and which includes all micro-
cystins, not just microcystin-LR”.19
The large variety of microcystins, combined with the limited
availability of standards, makes such analyses demanding.
Available methods include HPLC-UV, LC-MS, enzyme-linked
immunosorbent assays (ELISAs), and bioassays. LC-MS
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methods can measure the individual MC congeners present but
require high-tech instruments and experienced operators due to
the large numbers of MCs with molecular masses/transitions
that potentially could be present, including undescribed MC
congeners. The analytical challenges this poses is illustrated by
a recent LC-MS analysis of water from Hartbeespoort Dam,
South Africa, where the sample contained 18 MCs at levels
above the LoQ and a further 23 MC congeners at levels below
the LoQ.7 To provide certainty, an analytical method should
detect all MCs, regardless of whether analytical standards are
commercially available. To measure such low levels of
microcystins, and to detect them all, requires a very sensitive
analytical method with exceptionally broad speciﬁcity.
Immunoassays with a suitable antibody can potentially
identify all MCs (and NODs) and are well suited to screening
because they can be highly sensitive and cheap, they have high
sample throughput, and it is not necessary to possess all MCs as
standards provided the assay cross-reactivity is similar toward
all analogues. Several ELISAs for MCs are already commercially
available.21−23 However, data on cross-reactivity of the existing
assays are relatively limited, cross-reactivities often appear to
vary markedly from analogue-to-analogue, and many commer-
cial ELISA kits are too expensive for large surveillance programs
in developing countries.
With the exception of the ﬁrst antibody raised using MC-
LA,24 most MC antibodies and ELISAs have been produced by
raising antibodies to MC-LR.25−39 This approach can lead to a
preference for microcystins with arginine in position-4, with
some MCs being poorly recognized.29 MC-RR has also been
used for raising antibodies for ELISA development31,32 but
could be expected to be subject to similar limitations. To avoid
selection for speciﬁc microcystins, a conjugate of the unusual β-
amino acid Addapresent at position-5 in most MCs and
NODswas used to raise antibodies with good cross-reactivity
to a wide range of MCs.21,23 However, antibodies directed
solely at the Adda moiety should detect free Adda, which can
be produced by microbial degradation of MCs and is not
toxic40 and may not adequately recognize congeners containing
modiﬁed Adda units such as [DMAdda5]- and [ADMAdda5]-
MCs. Furthermore, such antibodies should recognize Adda-
containing ring-opened “linearized” seco-MCs. These are
produced during biosynthesis or hydrolysis of MCs but are,
however, much less toxic.41−47
Alternative strategies for the development of antibodies with
broad speciﬁcity for whole groups of analytes48 include
immunizing with hapten mixtures.49 In an attempt to avoid
producing antibodies with a preference for MCs containing
particular amino acids, we conjugated a carefully chosen
mixture of microcystins to cationized bovine serum albumin
(cBSA) for immunizing sheep. The resulting polyclonal
antisera, together with a plate-coating antigen derived from
[Asp3]MC-RY, were combined in an indirect competitive
ELISA with exceptional sensitivity and broad speciﬁcity. The
ELISA gave excellent results with cultures, spiked, and natural
samples.
■ MATERIALS AND METHODS
Materials. MC-LR, -LA, -LF, -LW, -YR, and -WR (1−6)
were from Enzo Life Sciences Inc. (Farmingdale, NY).
[Asp3]MC-RY (7) was fractionated from an HP-20 extract of
Microcystis aeruginosa culture NIVA-CYA 548.50 2-Hydrox-
ythiepan (2-HTP) was from Toronto Research Chemicals
(North York, ON, Canada). Sodium cyanoborohydride, bovine
serum albumin (BSA), ovalbumin (OVA), and Freund’s
incomplete adjuvant (FIA) were from Sigma−Aldrich (St.
Louis, MO). Cationized BSA (cBSA) was prepared by standard
Figure 1. Structures of microcystins discussed in the text.
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methods.51 Maxisorp immunoplates (96 ﬂat-bottom wells)
were from Nunc (Roskilde, Denmark), poly(vinylpyrrolidone)
25 (PVP) was from Serva Electrophoresis (Heidelberg,
Germany), rabbit antisheep−horseradish peroxidase conjugate
(antisheep−HRP) from Zymed (now Invitrogen, Paisley,
U.K.), and HRP-substrate K-blue Aq. from Neogen (Lexington,
KY). Nostoc 152 culture,52 from K. Sivonen (University of
Helsinki, Finland), was extracted to provide crude 14−16, and
a subsample of the extract was hydrolyzed to give crude 17−
19.7 Certiﬁed reference materials (CRMs) of MC-LR, MC-RR
(9), NOD-R, and [Dha7]MC-LR (10) were from the National
Research Council of Canada (NRC) (Halifax, NS, Canada).
Noncertiﬁed standards were obtained as follows: MC-LR, MC-
RR, MC-YR, MC-LA, MC-LF, MC-LY, MC-LW, and NOD-R
(Enzo Life Sciences, Farmingdale, NY); [Dhb7]MC-RR
(Cyano Biotech, Berlin, Germany); MC-LR (Abraxis-ELISA-
kit, Enzo Life Sciences); and [Dha7]MC-LR (AgResearch,
Hamilton, New Zealand). A reference material (RM)
(quantitated by LC-CLND) of MC-LA and nonquantitated
standards of MC-LF and MC-YR were from NRC. Inorganic
chemicals and organic solvents were reagent grade or better.
Plate-coating buﬀer was carbonate buﬀer (50 mM, pH 9.6).
Phosphate-buﬀered saline (PBS) contained NaCl (137 mM),
KCl (2.7 mM), Na2HPO4 (8 mM), and KH2PO4 (1.5 mM),
pH 7.4. ELISA washing buﬀer (PBST) was 0.05% Tween 20 in
PBS. Sample buﬀer was 10% methanol (v/v) in PBST, and
antibody buﬀer was 1% PVP (w/v) in PBST.
Cultures of M. aeruginosa were isolated from Hartbeespoort
Dam (−25.7475, 27.866944) and from the breeder dam at Le
Croc crocodile farm (−25.492467, 27.680450), North West
Province, South Africa. These produced a range of microcystin
variants (Tables S1−S6, Supporting Information) and were
used to test ELISA performance.
[Asp3]MC-RY (7). A culture (3 L) of NIVA-CYA 548 was
extracted with HP-20 resin and then eluted.50 The eluate was
evaporated to dryness, dissolved in MeOH−water (1:4, 5 mL),
and chromatographed (SPE cartridge, Hypersep C18, 500 mg,
3 mL; Thermo Scientiﬁc) with a stepwise gradient of MeOH
(30, 40, 45, 50, 55, 60, 70, 80, 90, and 100%) in water (5 mL
per step). LC-MS revealed 98% of 7 in the 40 and 45%
fractions (together with 31% of 8), which were combined. This
fraction was further puriﬁed by SPE, with a gradient of MeOH
(25, 30, 35, 40, 45, 50, and 90%) in water (5 mL per step). The
40% fraction contained 67% of the [Asp3]MC-RY (7),
essentially free of 8 or other peptides by LC-MS, and an
aliquot containing 100 μg of 7 was evaporated to dryness under
a stream of nitrogen.
Immunogen. MC-LA (2), -LF (3), -LW (4), -YR (5), and
-WR (6) (100 μg each) were dissolved together in MeOH (2
mL), added to a suspension of 2-HTP (550 μg) in MeOH−
MeCN (1:1, 600 μL) plus tetrahydrofuran (THF) (200 μL),
and held at 40 °C. After 1 h, carbonate buﬀer (pH 9.2, 50 μL,
0.2 M) was added and held at 40 °C for 2 h and then overnight
at ca. 20 °C. Most of the organic solvent was removed under a
stream of nitrogen, PBS was added (1 mL), and the residual
organic solvent removed under a stream of nitrogen. The ice-
cold solution was carefully washed with diethyl ether (4 × 2
mL) to remove unreacted 2-HTP and brieﬂy held under a
stream of nitrogen to remove residual ether.
This mixed-MC-hapten solution was added to 10 mg of
cBSA in 3.0 mL of PBS, and 100 μL of sodium
cyanoborohydride (50 mg/mL in water) was added to form
the immunogen (Figure 2). After 2 h, another 50 μL of
cyanoborohydride solution was added and the reaction mixture
stored overnight at 4 °C. The immunogen was washed through
multiple centrifugations with PBS in a Vivaspin 2.0 mL
concentrator with 10 000 MW cutoﬀ (Sartorius Stedim Biotech
GmbH, Goettingen, Germany) to remove unbound micro-
cystins and excess reagents. The immunogen (MC-mix−cBSA)
was aliquotted, lyophilized, and stored at −20 °C.
Plate-Coating Antigen. [Asp3]MC-RY (7) (100 μg) in
MeOH (400 μL) was added to carbonate buﬀer (pH 9.7, 100
μL, 0.2 M), followed by a suspension of 2-HTP (91 μg) in
THF−MeOH (10:1), and the mixture was allowed to react at
ambient temperature. After 16 h, carbonate buﬀer (200 μL) was
added and the reaction held at 40 °C, and then a further 200 μL
of buﬀer was added 24 h after that. The hapten was separated
from excess 2-HTP and unreacted 7 by SPE (Hypersep C18,
500 mg, 3 mL; Thermo Scientiﬁc) with a step-gradient of
MeOH in water (10, 20, 30, 40, 50, 60, and 80%, 5 mL per
step). LC-MS showed the hapten in the 40% MeOH fraction,
which was evaporated under a stream of nitrogen, dissolved in
MeOH−water (1:1, 100 μL), and PBS (100 μL) was added.
This solution was mixed with 10 mg of OVA in 800 μL of PBS.
NaBH3CN (5 mg in 100 μL water) was added to form the
plate-coating antigen (OVA−[Asp3]MC-RY, Figure 2), which
was washed, aliquotted, lyophilized and stored as for the
immunogen.
LC-MS. LC-MS2 analysis was as described previously.50
Quantitation was performed in scan mode (m/z 900−1200)
relative to the most appropriate standard (e.g., MC-LR for
microcystins containing a single Arg residue, etc.) using the [M
+ H]+ ions. Conﬁrmation of the identities of the microcystins
and their 2-HTP-derivatives was obtained by examination of
the compounds’ MS2 spectra as described elsewhere.50
Polyclonal Antibodies. Three sheep (Nor X breed) were
immunized with MC-mix−cBSA. Immunogen was prepared as
an oil-in-water emulsion by mixing antigen (200 μg in 0.6 mL)
Figure 2. Structures of the immunogen and plate-coating antigen. The
immunogen consisted of an equal mix of MC-LA, MC-LF, MC-LW,
MC-YR, and MC-WR conjugated to cBSA, whereas the plate-coating
antigen consisted of [Asp3]MC-RY conjugated to OVA, both
conjugated through a thiol linker at position-7 (see Scheme S1 in
the Supproting Information). For each analogue, the amino acids
(standard 3- and 4-letter codes) at each of the seven positions are
shown below the structure. Amino acids common to all the
immunogen components, and to the plate coating antigen, are
shown in italic text.
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and FIA (0.4 mL) in a sterile syringe and administered
subcutaneously near the supramammary lymph node at 4-
weekly intervals. Test bleeds (10 mL) were taken from the
jugular vein 2 weeks after the second immunization. After the
fourth and subsequent immunizations, bulk bleeds of up to 450
mL were collected in blood bags (Fenwal, Lake Zürich, IL) 2
weeks after immunization. The antisera were separated by
centrifugation at 3000 rcf for 20 min (Jouan Br4i Centrifuge
with S40 rotor, Jouan, Saint-Herblain, France), aliquotted and
stored at −20 °C. Animal experiments were in accordance with
the three R’s, laws, and regulations and approved by The
Norwegian Animal Research Authority.
ELISA. Maxisorp immunoplates were coated with plate-
coating antigen (Figure 2) (in coating buﬀer, 100 μL/well)
overnight at room temperature. After incubation, excess was
removed by aspiration and the plates were washed four times
with PBST and blocked for 1 h with 1% PVP in PBST (200
μL/well) and then washed twice with PBST.
Noncompetitive assays were used to estimate titers of the
antisera giving maximal absorbance of 1.0. This was done by
combining equal volumes (50 μL) of sample buﬀer (10%
MeOH−PBST) and a dilution series of antisera in antibody
buﬀer (1% PVP−PBST) in the wells and incubating for 1 h.
After washing four times with PBST, bound antibody was
detected by adding antisheep−HRP conjugate in antibody
buﬀer (100 μL at 1:3000) for 2 h and then washing four times
before addition of the HRP substrate (100 μL/well). After 15
min, the reaction was stopped by adding 50 μL of 10% H2SO4,
and absorbances were measured at 450 nm using a plate reader
(Wallac 1420 Victor2 multilabel counter, Wallac, Turku,
Finland). All incubations were performed at ca. 20 °C.
Competitive ELISAs were performed (as above) by adding
appropriate amounts of standard or sample and antiserum to
the wells after blocking. Standards in methanol, usually MC-LR
(500 ng/mL), were diluted in PBST to give a methanol
concentration of 10%, and then in a threefold dilution series in
sample buﬀer, giving standard concentrations of 50, 16.7, 5.56,
0.62, 0.20, 0.069, 0.023, 0.0076, and 0.0025 ng/mL. All sample
and standard dilutions were done in duplicate. The remaining
ELISA steps were done as above for the noncompetitive ELISA.
Optimal concentrations of plate-coating antigen (2 μg/mL),
antiserum 80289 (1:6500), and antisheep−HRP (1:3000) were
determined by checkerboard titrations followed by optimization
of the standard curve. Assay standard curves were calculated
using logistic treatment of the data. The assay working range
was deﬁned as the linear region at 20−80% of maximal
absorbance (Amax).
Cross-Reactivity. The relative sensitivity of the immuno-
assay toward the available MCs and NOD-R was determined by
assaying a dilution series of each compound in sample buﬀer.
The I50 values (molar concentration giving 50% inhibition)
were expressed as a percent I50 relative to the MC-LR CRM.
Matrix Eﬀects. Tap water (Oslo, Norway) and non-
microcystin-producing M. aeruginosa cultures (NIVA-CYA 841,
NIVA-CYA 843, NIVA-CYA 845, NIVA CYA 848, and NIVA-
CYA 849) were analyzed in duplicate in dilution series. Initial
studies indicated a matrix eﬀect suppressing the signal in the
ﬁrst dilution. This was investigated by running a non-
competitive ELISA with dilution series of tap water samples
and measuring the eﬀect on Amax of addition of MeOH, PBS,
and/or Tween 20. Based on this, 10-times concentrated PBST
(45 μL) and 50 μL MeOH were added to samples (405 μL) of
water and algal cultures, so that the ionic strength, pH, Tween
20, and MeOH concentrations were similar to those in the
sample buﬀer. Consequently, the initial sample dilution is 1.2-
fold, which is corrected for during data processing.
Validation. The optimized assay was validated by spiking
MC-LR CRM into tap water and a non-MC-producing M.
aeruginosa culture (NIVA-CYA 845). The tap water and culture
samples were freeze−thawed twice, and to aliquots (4.05 mL)
of each were added the following: MC-LR (0, 10, 25, 50, or 100
μL; 50 μg/L in MeOH); MeOH (500, 490, 475, 450, or 400
μL); and 10-times concentrated PBST (450 μL). Each spiked
sample thus contained 4.05 mL of culture or water, 0.5 mL of
MeOH, and 0.45 mL of conc. PBST, giving a total volume 5.0
mL with MC-LR at 0, 0.1, 0.25, 0.5, and 1.0 μg/L. Aliquots of
the spiked samples were frozen and stored at −20 °C until
analysis. Each sample was assayed in eight replicates per plate.
The total number of plates was seven, with the assay performed
on ﬁve diﬀerent days for the tap water, and with six plates on
four diﬀerent days for the algal culture. Recoveries were
estimated by comparing the ELISA results with the calculated
MC-LR concentrations.
Intra-assay variation was determined from variation of the
mean MC-LR concentration of each of the eight replicates for
the four diﬀerent concentrations on one plate. The interassay
(interplate) variation was determined from variation of the
mean MC-LR concentrations on each plate over 5 days for the
tap water and 4 days for the spiked cultures.
Analysis of Cultures. Eleven M. aeruginosa cultures
(NIVA-CYA 840−849 and AB2013 07) were freeze−thawed
twice and ultrasonicated (Branson 3200, Soest, Netherlands)
for 10 min. Samples were analyzed directly by ELISA (starting
with a 1.2-fold dilution with 10-times concentrated PBS
followed by a threefold dilution series with sample buﬀer).
Aliquots of the ultrasonicated cultures were also diluted with an
equal volume of MeOH and ﬁltered (Spin-X 0.22 μm nylon,
Costar, Corning, NY), and the ﬁltrates were analyzed by both
ELISA (starting with a 10-fold dilution to adjust for MeOH in
the assay) and LC-MS.
■ RESULTS AND DISCUSSION
Hapten and Conjugation. Deciding which substructures
within the analyte should be recognized by the antibodies, and
which should not be recognized, is a critical step in designing
hapten chemistry to generate an immunoassay with appropriate
speciﬁcity. Just as important, in the case of microcystins with
numerous variants with modiﬁcations in many positions, is it to
balance the preference of the antibodies for certain groups/
amino acids in order to achieve uniform cross-reactivity.
We wished to produce antibodies with broad cross-reactivity
to microcystins and, if possible, nodularins, while avoiding a
strong preference for particular amino acids, such as Adda. We
therefore aimed to produce antibodies recognizing the general
cyclic peptide structure of microcystins, but without a high
degree of speciﬁcity for particular amino acid side-chains
present at positions 2−4 and 7, which are the most variable in
MCs.
Immunogen. Therefore, we applied a multihapten strategy
using an immunogen containing microcystins with a variety of
amino acids at position-2 (Leu, Tyr, and Trp) and -4 (Ala, Phe,
Trp, and Arg). MC-LA, -LF, -LW, -YR, and -WR were selected
for the immunogen (Figure 2), in the hope that the immune
response would be directed to the common structural elements
shared by these congeners.
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The antibodies’ ability to recognize the large variety of
microcystins depends on the choices made about the
orientation of the hapten on the immunogen and on the
plate-coating antigen. There are three approaches for
conjugation of microcystins to carrier proteins: (a) through
the carboxylic acids in positions 3 and/or 6 using
carbodiimides,24,25,28,30,33,35 (b) through coupling using gluta-
raldehyde,34,37 or (c) through the double bond in position-7
using aminoethanethiol.27,29,31,36,38,39
We chose thiol derivatization at position-7 with 2-HTP, a
cyclic thiohemiacetal. In hydroxylic solvents, 2-HTP exists in
equilibrium with its ring-opened thioaldehyde form, and, in
weak base, the thiolate reacts readily with activated double
bonds via Michael addition (Scheme S1, Supporting
Information) to introduce a short side-chain containing an
aldehyde.53 Reactions of 2-HTP with microcystins were
monitored by LC-MS analysis and were terminated when the
reactions were >95% complete. Aldehydes react eﬃciently with
amino groups on proteins via reductive amination in the
presence of sodium cyanoborohydride,51 and this procedure
was used for coupling the 2-HTP-derivatized microcystins to
the carrier proteins (Scheme S1, Supporting Information).
Plate-Coating Antigen. For small molecules such as
microcystins, ELISA format options are limited to competitive
assays, where the antibody can bind either to the microcystin
on the plate-coating antigen or to free microcystins from the
sample. Because the assay is based on competition between the
plate-coating antigen and the analyte for the antibody’s binding
sites, the plate-coating chemistry is important when developing
a competitive immunoassay, especially with polyclonal antisera.
To complement our mixed-immunogen approach, we wished to
use a plate-coating antigen made from a hapten that shared
none of the amino acids present in the “variable” positions 2−4
in the haptens of the mixed immunogen (Figure 2). Few such
microcystins are commercially available; however, [Asp3]MC-
RY was conveniently isolated from M. aeruginosa culture
(NIVA-CYA 548)50 and conjugated to ovalbumin (Scheme S1,
Supporting Information) (Figure 2). Thus, antibodies in the
antiserum that are capable of binding to the plate-coating
antigen would be expected to be those with a strong aﬃnity for
microcystin-like cyclic peptides, but without a strong preference
for particular amino acid side-chains in positions 2−4.
Furthermore, the site of conjugation of all the haptens is
position-7, (Figure 2), which is proximal to the carrier protein
and therefore unlikely to generate antibodies directed toward it.
Thus, the immunogen/plate-coating antigen combination used
to develop this assay was expected to lead to an assay
recognizing MCs, but without a strong preference for which
amino acids are present at position-2, -3, -4, and -7. As these are
the four most common sites of variation in the known MCs,18 it
was hoped that the resulting ELISA would possess broad
speciﬁcity toward MCs and might even detect NODs.
Antibodies. Microcystin-speciﬁc antibodies were detectable
by indirect ELISA in antisera from all three sheep after the ﬁrst
booster injection. Antiserum titers were determined by
noncompetitive ELISA. Antiserum from sheep 80289 gave
the highest antibody titer and was usable at 1:6500 dilution
after ﬁve immunizations. The titer increased with increasing
concentrations of plate-coating antigen for sheep 80289 and
80206, but not for 90164. Screening for competition was
performed with MC-LR, and 50% inhibition was obtained at
258 and 295 pg/mL for sheep 80289 and 80206, respectively,
in the unoptimized assay. Based on standard curves with a
range of microcystins, assay development proceeded using
serum from the ﬁfth bleed from sheep 80289 (80289-5b).
Unoptimized ELISA analyses showed that antibodies in the
antiserum recognized OVA−[Asp3]MC-RY and that binding
was inhibited in a concentration-dependent manner by MC-LR
(Figure S2, Supporting Information). This indicated that the
antibodies produced by immunization with the MC-mixture
recognized both [Asp3]MC-RY (on the plate coating antigen)
and MC-LR and might have the desired cross-reactivity
characteristics.
Table 1. Molar Cross-Reactivities of Antiserum 80289-5b with a Series of Microcystin Analogues
assay range (pg/mL)a
compound origin quantitation n I20 I80 I50 MW I50 (nM) % CR
b
MC-LRc NRC NMR/CLND 15 40 882 187 994.5 189 100
MC-RRc NRC NMR/CLND 4 54 1089 243 1037.5 234 80
NOD-Rc NRC NMR/CLND 3 42 1122 216 824.9 261 72
[Dha7]MC-LRc NRC NMR/CLND 3 44 905 200 980.5 204 92
MC-LA NRCd CLND 4 56 1141 252 909.5 277 68
MC-LF NRCe as per label 4 43 811 187 1044.5 189 100
MC-YR NRCd as per label 3 89 1570 372 985.5 356 53
MC-LR Enzo as per label 15 44 899 198 994.5 199 95
MC-RR Enzo as per label 3 115 1942 462 1037.5 445 42
NOD-R Enzo as per label 4 52 1388 269 824.9 326 58
MC-YR Enzo as per label 3 133 1755 476 1044.5 456 41
MC-LA Enzo as per label 4 92 1810 404 909.5 444 42
MC-LF Enzo as per label 3 78 1172 299 985.5 304 63
MC-LY Enzo as per label 3 114 1499 411 1001.5 411 46
MC-LW Enzo as per label 3 51 863 209 1024.5 204 93
[Dha7]MC-LR AgResearch as per label 4 98 2071 449 980.5 457 41
MC-LR Abraxis as per label 2 62 975 239 994.5 240 79
[Dhb7]MC-RR Cyano as per label 3 86 1869 396 1023.5 387 49
aI20, I50, I80 are the concentrations of analogue giving 20, 50 and 80% inhibition, respectively, of binding of antibody to the coating antigen (OVA−
[Asp3]MC-RY). b% CR = 100 × (I50 MC-LR CRM)/(I50 analogue). Interassay variation (CV) was 4−24% for I50-values based on 2−15 competition
curves. cCertiﬁed reference material (CRM). dOriginally from Sigma−Aldrich. eOriginally from Enzo Life Sciences Inc.
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ELISA Optimization. In a sensitive ELISA, the assay
conditions, such as the concentration of reagents, the blocking
agent, temperature, etc. need to be optimized. Criteria used to
evaluate optimization were maximum absorbance, working
range (I20−I80), I50, slope of the curve, and limit of
quantiﬁcation (I20 based on a mean of several assays and
multiplied by the dilution factor (i.e., 1.2 for water and culture
samples and 10 for MeOH-extracts)). Optimal concentrations
of assay reagents were determined by checkerboard titrations
and standard curves. Based on the means from 13 assays using
the MC-LR CRM, the optimized assay had a working range
(I20−I80) of 40−882 pg/mL, and the I50 was 187 pg/mL.
Speciﬁcity. The response of the optimized assay to MC-LR,
MC-RR, MC-LA, MC-LF, MC-YR, [Dha7]MC-LR, MC-LY
(11), MC-LW, [Dhb7]MC-RR (12) (Figure 1), and NOD-R
(Figure S1, Supporting Information) was tested over a range of
concentrations to determine cross-reactivity (Table 1 and
Figure S2, Supporting Information). All microcystin standards
caused concentration-dependent inhibition of antibody binding.
Based on I50 values, the molar cross-reactivities relative to MC-
LR were 68−100% for the RM/CRMs of microcystins and
nodularin and 41−100% for all microcystins tested (Table 1).
The antibodies in the assay therefore have a similar aﬃnity for
these other microcystins and nodularin as they do for MC-LR.
Because they were raised against whole MC-congeners, rather
than an Adda-containing fragment, we expect that the
antibodies would not cross-react strongly with Adda itself but
were not able to obtain a standard of Adda to test this.
However, the assay responded to [ADMAdda5]- (14−16) and
[DMAdda5]-microcystins (17−19) in the Nostoc 152 extract
and its hydrolysate, indicating cross-reactivity toward MCs
containing modiﬁed Adda-analogues, although the degree of
cross-reactivity could not be measured due to the unavailability
of pure quantitative standards. NOD-R diﬀers from MC-LR
only in the absence of the Ala1 and Leu2 (present in MC-LR)
and methyl substitution of the oleﬁnic group at position-7
(Mdhb instead of Mdha). Thus, the minimal reduction in cross-
reactivity toward NOD-R (72%), relative to MC-LR, conﬁrms
that the antibodies in the assay do not have a strong
requirement for the amino acids at positions-1, -2, and -7.
The high cross-reactivities of [Dha7]MC-LR (92%) and MC-
LA (68%) also indicate that the N-methyl group at position-7
and the amino acid at position-4 have little eﬀect on antibody
recognition. That the competitive ELISA format relies on
inhibition of binding of antibody to the [Asp3]MC-RY-
containing plate coating antigen, which diﬀers at positions-2,
-3, and -4 from both MC-LR and from all the congeners used in
the immunogen, suggests the assay will detect MCs with
variants at these positions. These results indicate that good
cross-reactivity can be expected for MC congeners varying at
position-7, -1, -2, -3, or -4, which covers ca. 80% of the MC
congeners reported in the literature,18 with some cross-
reactivity (not yet quantiﬁed) for congeners varying at
position-5. The ELISA therefore appears to be capable of
detecting over 90% of the reported MC congeners. It should be
noted, however, that although the assay estimates the total
content of MCs, this does not necessarily reﬂect the toxicity of
the sample because the congeners’ structures aﬀect their
toxicities. In addition to free MCs, the ELISA can also be
expected to cross-react strongly with conjugated MCs
especially those formed via conjugation of cysteinyl residues
to position-7 (e.g., cysteine and glutathione conjugates).
Standards. The availability of reliable standards is
important during development and validation of analytical
methods. One obstacle in this study was the relatively limited
array of MC analogues for cross-reactivity studies. Another
problem was the apparent quantitative variation in the
commercial standards supplied, relative to the RM/CRMs
from NRC. This resulted in measured cross-reactivities (Table
1) that were as little as one-half of those obtained with the
CRMs from NRC, presumably due to diﬀerences in
concentration. This interstandard variation made it diﬃcult to
establish true values for cross-reactivities for analogues for
which no independently quantitated standards were available.
Availability of good standards and reference materials is
important for all analytical methods, and the criteria for what
constitutes a good standard may vary between analytical
methods. For example, standards adequate for LC-MS may
contain contaminating analogues which do not interfere with
quantitation due to their diﬀerences in mass and retention time.
However, for antibody- and protein-phosphatase-based detec-
tion, contaminating microcystin analogues can aﬀect the
response. And, even for highly pure standards, all analytical
methods require standards to be quantitatively accurate in
order to produce reliable results. Therefore, cross-reactivity
data in this and other studies should be regarded only as
indicative, except where high-purity quantitatively veriﬁed
standards have been used.
Matrix Eﬀects. Tap water gave matrix eﬀects when
undiluted, seen as a suppressed signal. Suspecting that this
was caused by the diﬀerences in ionic strength, pH, and Tween
content between the sample (fresh water) and the assay buﬀer,
we tested addition of the assay-buﬀer components (MeOH,
PBS, and/or Tween 20) to the sample such that their
concentration in the sample was the same as in the assay
buﬀer. This is illustrated in Figure S3 (Supporting Information)
where Amax-values (relative to sample buﬀer) from the
treatments are shown after a range of dilutions. Addition of
PBST and MeOH, such that the concentration of MeOH, PBS,
and Tween 20 in the sample was the same as in the sample
buﬀer, completely abolished matrix eﬀects without dilution
being required. Thus, to analyze samples of fresh water and
algal cultures with minimal dilution, we adjusted for the lack of
salt, buﬀer, and Tween-20 as described in Materials and
Methods.
Validation. The optimized ELISA was validated by spiking
MC-LR into samples of tap water and the nonmicrocystin-
producing M. aeruginosa culture NIVA-CYA 845. The samples
were spiked with four concentrations of MC-LR (Table 2),
with the content of PBS and Tween adjusted as described
above. Recoveries were determined by comparing the ELISA
results with the calculated MC-LR concentrations.
The measured concentrations of MC in spiked water were
91−120% (Table 2) of the calculated concentrations of MC-
LR, with a mean recovery of 105%, while the measured
concentrations in the spiked culture samples were 87−106%,
with a mean recovery of 99% (Table 2). Both recoveries are
well within the acceptable limits for assay recovery (100% ±
20). The mean interassay coeﬃcient of variation was 9.5%,
while the mean intraassay coeﬃcient of variation was 15% for
the spiked cultures.
Analysis of Cyanobacterial Cultures. To conﬁrm its
applicability to real samples, the ELISA used to analyze MCs in
11 cyanobacterial cultures (Figure 3 and Table S7, Supporting
Information). These cultures were also analyzed by LC-MS for
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comparison. Cultures of NIVA-CYA 844, 845, 848, and 849
were negative by both methods. Very low levels of microcystins
were detected in NIVA-CYA 841, 842, and 843 by ELISA
(0.20, 0.36, and 0.07 ng/mL) when analyzed directly, whereas
the 50% MeOH extracts (which necessitate starting at a 10-fold
dilution for the ELISA due to the MeOH content) of these
cultures were negative by both ELISA and LC-MS. Cultures of
NIVA-CYA 840, 846, and 847 and of strain AB2013-07 were
strongly positive and contained similar amounts of MCs by
both methods (Figure 3). By LC-MS, NIVA-CYA 840 was
dominated by [Asp3]MC-LR and [Asp3,Dha7]MC-LR, NIVA-
CYA 846, and NIVA-CYA 847 by [Asp3]MC-RY and
[Asp3]MC-LY, and AB2013-07 by MC-LR, MC-YR, and MC-
LA. The small diﬀerences between the LC-MS and ELISA
results may be due to diﬀerences in the standards (the LC-MS
method did not use the CRMs), cross-reactivities in the ELISA,
matrix eﬀects, and variation in interanalogue response factors in
the LC-MS. Indeed, the data in Table 1 suggest that some
commercial microcystin standards may contain signiﬁcantly less
toxin than stated on the label, and use of such standards in the
LC-MS would lead to overestimation of the microcystin
content of samples. Nevertheless, the LC-MS and ELISA
analyses parallel each other closely (slope 0.8, R2 0.98; Figure
3), despite major diﬀerences in microcystin proﬁles (Tables
S1−S6 of the Supporting Information) in these cultures. This,
together with the absence of false positives in the non-
microcystin-producing cultures, conﬁrms the broad cross-
reactivity of the ELISA and its utility for analysis of naturally
contaminated samples.
In summary, we report development of an ELISA with broad
speciﬁcity for MCs and NODs, so that the total content of
analogues and metabolites can be measured. Suitable antibodies
were obtained using an immunogen containing a carefully
chosen mixture of MCs, and the antiserum, when used with a
plate-coating antigen containing a microcystin with comple-
mentary structural elements, resulted in an ELISA with
exceptional sensitivity and broad speciﬁcity. The reagents
should be suitable for the development of other immunoassay
formats, including biosensors, and the broad speciﬁcity of the
antibodies makes them suitable for immunoaﬃnity cleanup and
preconcentration prior to HPLC or LC-MS analysis. The
multihapten approach used here may be useful for other analyte
families where broad, but high speciﬁcity is required for a large
group of structurally related congeners.
This ELISA provides a sensitive and rapid analytical method
that uses inexpensive instrumentation for analyzing MCs in
water samples. Although the cross-reactivities for MC
congeners tested in the assay were 42−100%, some of this
variability appears to be due to the quality of the available
standards. It is therefore highly desirable that a wider range of
independently quantitatedand, preferably, certiﬁedmicro-
cystin standards become available to facilitate validation of
chromatographic, immunoassay, and bioassay methods for this
important group of cyanobacterial toxins.
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Table 2. ELISA Analysis of Tap Water and Microcystis
Culture NIVA-CYA 845 Spiked with MC-LR
concentration (μg/L)
matrix MC-LR added MCs by ELISA % na CV (%)
tap water 0 0.01 − 7 58c
tap water 0.1 0.12 120 7 18
tap water 0.25 0.25 100 7 13
tap water 0.5 0.54 108 7 12
tap water 1b 0.91 91 7 15
culture 0 0.01 − 6 73c
culture 0.1 0.10 100 6 10
culture 0.25 0.22 87 6 17
culture 0.5 0.51 103 6 5
culture 1b 1.06 106 6 6
aNumber of separate assays run. bMaximum level in drinking water as
recommended by WHO.19,20 cMeasured percentage CVs for micro-
cystin-free samples are high because the concentrations are below the
LOQ.
Figure 3. Total microcystins by ELISA and LC-MS for 11 M.
aeruginosa cultures (ELISA results of cultures compared to LC-MS on
culture extracts). Details in Table S7, Supporting Information.
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■ ABBREVIATIONS USED
2-HTP 2-hydroxythiepan
Adda 3-amino-9-methoxy-2,6,8-trimethyl-10-phenyl-4,6-
decadienoic acid
ADMAdda 9-acetoxyDMAdda
cBSA cationized bovine serum albumin
CLND chemiluminescence nitrogen detector
CRM certiﬁed reference material
DMAdda 9-desmethylAdda
ELISA enzyme-linked immunosorbent assay
FIA Freund’s incomplete adjuvant
HRP horseradish peroxidase
MC microcystin
NOD nodularin
NRC National Research Council of Canada
OVA ovalbumin
PBS phosphate-buﬀered saline
PBST PBS with 0.05% Tween 20
PVP poly(vinylpyrrolidone) 25
RM reference material
SPE solid-phase extraction
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